{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T09:56:41Z","timestamp":1790416601818,"version":"4.1.0"},"reference-count":20,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,7,9]],"date-time":"2020-07-09T00:00:00Z","timestamp":1594252800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,7,9]],"date-time":"2020-07-09T00:00:00Z","timestamp":1594252800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Qingdao science and technology project","award":["20-4-1-5-nsh"],"award-info":[{"award-number":["20-4-1-5-nsh"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ital J Pediatr"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n<jats:title>Background<\/jats:title>\n<jats:p>MED13L-related intellectual disability is a new syndrome that is characterized by intellectual disability (ID), motor developmental delay, speech impairment, hypotonia and facial dysmorphism. Both the MED13L haploinsufficiency mutation and missense mutation were reported to be causative. It has also been reported that patients carrying missense mutations have more frequent epilepsy and show a more severe phenotype.<\/jats:p>\n<\/jats:sec><jats:sec>\n<jats:title>Case presentation<\/jats:title>\n<jats:p>We report a child with ID, speech impairment, severe motor developmental delay, facial deformity, hypotonia, muscular atrophy, scoliosis, odontoprisis, abnormal electroencephalogram (EEG), and congenital ureteropelvic junction obstruction (UPJO) combined with high ureter attachment. We used whole-exome sequencing (WES) to detect the genetic aberration of the child and found a de novo mutation, c.2605C\u2009&gt;\u2009T (p.Pro869Ser), in the <jats:italic>MED13L<\/jats:italic> gene. Neither of her parents carried the mutation. Additionally, we review the literature and summarize the phenotypes and features of reported missense mutations. After reviewing the literature, approximately 17 missense mutations in 20 patients have been reported thus far. For 18 patients (including our case) whose clinical manifestations were provided, 100% of the patients had ID or developmental delay (DD). A total of 88.9, 83.3 and 66.7% of the patients had speech impairment, delayed milestones and hypotonia, respectively. A total of 83.3% of the patients exhibited craniofacial deformity or other dysmorphic features. Behavioral difficulties and autistic features were observed in 55.6% of the patients. Cardiac anomalies were seen in only 27.8% of the patients. Of these patients, 44.4% had epileptic seizures. Of the 17 mutations, 2 were located in the N-terminal domain, 8 were located in the C-terminal domain, and 1 was located in an \u03b1-helical sequence stretch. One of them was located in the MID domain of the MedPIWI module.<\/jats:p>\n<\/jats:sec><jats:sec>\n<jats:title>Conclusions<\/jats:title>\n<jats:p>We report a new patient with a reported missense mutation, c.2605C\u2009&gt;\u2009T (p.Pro869Ser), who exhibited some infrequent manifestations except common phenotypes, which may broaden the known clinical spectrum. Additionally, by reviewing the literature, we also found that patients with missense mutations have a higher incidence of seizures, MRI abnormalities, autistic features and cardiac anomalies. They also have more severe ID and hypotonia. Our case further demonstrates that Pro869Ser is a hotspot mutation of the <jats:italic>MED13L<\/jats:italic> gene.<\/jats:p>\n<\/jats:sec>","DOI":"10.1186\/s13052-020-00847-y","type":"journal-article","created":{"date-parts":[[2020,7,9]],"date-time":"2020-07-09T16:06:44Z","timestamp":1594310804000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["Report of a de novo c.2605C &gt; T (p.Pro869Ser) change in the MED13L gene and review of the literature for MED13L-related intellectual disability"],"prefix":"10.1186","volume":"46","author":[{"given":"Zhi","family":"Yi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhenfeng","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong","family":"Pan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chengqing","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fei","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiao","family":"Xue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4684-8651","authenticated-orcid":false,"given":"Zhenghai","family":"Qu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,7,9]]},"reference":[{"key":"847_CR1","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1016\/j.molcel.2004.05.006","volume":"14","author":"S Sato","year":"2004","unstructured":"Sato S, Tomomori-Sato C, Parmely TJ, Florens L, Zybailov B, Swanson SK, et al. A set of consensus mammalian mediator subunits identified by multidimensional protein identification technology. Mol Cell. 2004;14:685\u201391. https:\/\/doi.org\/10.1016\/j.molcel.2004.05.006.","journal-title":"Mol Cell"},{"key":"847_CR2","doi-asserted-by":"publisher","first-page":"2843","DOI":"10.1161\/01.cir.0000103684.77636.cd","volume":"108","author":"N Muncke","year":"2003","unstructured":"Muncke N, Jung C, Rudiger H, Ulmer H, Roeth R, Hubert A, et al. Missense mutations and gene interruption in PROSIT240, a novel TRAP240-like gene, in patients with congenital heart defect (transposition of the great arteries). Circulation. 2003;108:2843\u201350. https:\/\/doi.org\/10.1161\/01.cir.0000103684.77636.cd.","journal-title":"Circulation"},{"key":"847_CR3","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/j.gene.2004.02.044","volume":"332","author":"L Musante","year":"2004","unstructured":"Musante L, Bartsch O, Ropers HH, Kalscheuer VM. cDNA cloning and characterization of the human THRAP2 gene which maps to chromosome 12q24, and its mouse ortholog Thrap2. Gene. 2004;332:119\u201327. https:\/\/doi.org\/10.1016\/j.gene.2004.02.044.","journal-title":"Gene"},{"key":"847_CR4","doi-asserted-by":"publisher","first-page":"1100","DOI":"10.1038\/ejhg.2013.17","volume":"21","author":"R Asadollahi","year":"2013","unstructured":"Asadollahi R, Oneda B, Sheth F, Azzarello-Burri S, Baldinger R, Joset P, et al. Dosage changes of MED13L further delineate its role in congenital heart defects and intellectual disability. Eur J Hum Genet. 2013;21:1100\u20134. https:\/\/doi.org\/10.1038\/ejhg.2013.17.","journal-title":"Eur J Hum Genet"},{"key":"847_CR5","doi-asserted-by":"publisher","first-page":"1311","DOI":"10.1002\/humu.22636","volume":"35","author":"M Doco-Fenzy","year":"2014","unstructured":"Doco-Fenzy M, Genevieve D, Sarda P, Edery P, Isidor B, Jost B, et al. Impaired development of neural-crest cell-derived organs and intellectual disability caused by MED13L haploinsufficiency. J Med Genet. 2014;35:1311\u201320. https:\/\/doi.org\/10.1002\/humu.22636.","journal-title":"J Med Genet"},{"key":"847_CR6","doi-asserted-by":"publisher","first-page":"1308","DOI":"10.1038\/ejhg.2015.26","volume":"23","author":"A Adegbola","year":"2015","unstructured":"Adegbola A, Musante L, Callewaert B, Maciel P, Hu H, Isidor B, et al. Redefining the MED13L syndrome. Eur J Hum Genet. 2015;23:1308\u201317. https:\/\/doi.org\/10.1038\/ejhg.2015.26.","journal-title":"Eur J Hum Genet"},{"key":"847_CR7","doi-asserted-by":"publisher","first-page":"1499","DOI":"10.1038\/ejhg.2015.19","volume":"23","author":"C Cafiero","year":"2015","unstructured":"Cafiero C, Marangi G, Orteschi D, Ali M, Asaro A, Ponzi E, et al. Novel de novo heterozygous loss-of-function variants in MED13L and further delineation of the MED13L haploinsufficiency syndrome. Eur J Hum Genet. 2015;23:1499\u2013504. https:\/\/doi.org\/10.1038\/ejhg.2015.19.","journal-title":"Eur J Hum Genet"},{"key":"847_CR8","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1038\/ejhg.2014.69","volume":"23","author":"MM van Haelst","year":"2015","unstructured":"van Haelst MM, Monroe GR, Duran K, van Binsbergen E, Breur JM, Giltay JC, et al. Further confirmation of the MED13L haploinsufficiency syndrome. Eur J Hum Genet. 2015;23:135\u20138. https:\/\/doi.org\/10.1038\/ejhg.2014.69.","journal-title":"Eur J Hum Genet"},{"key":"847_CR9","doi-asserted-by":"publisher","first-page":"1264","DOI":"10.1002\/ajmg.a.38168","volume":"173","author":"T Yamamoto","year":"2017","unstructured":"Yamamoto T. MED13L haploinsufficiency syndrome: a de novo frameshift and recurrent intragenic deletions due to parental mosaicism. Clin Case Rep. 2017;173:1264\u20139. https:\/\/doi.org\/10.1002\/ajmg.a.38168.","journal-title":"Clin Case Rep"},{"key":"847_CR10","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1002\/ajmg.a.38536","volume":"176","author":"CT Gordon","year":"2018","unstructured":"Gordon CT, Chopra M. MED13L loss-of-function variants in two patients with syndromic Pierre Robin sequence. Am J Med Genet A. 2018;176:181\u20136. https:\/\/doi.org\/10.1002\/ajmg.a.38536.","journal-title":"Am J Med Genet A"},{"key":"847_CR11","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1016\/j.ejmg.2018.06.014","volume":"62","author":"PM Torring","year":"2019","unstructured":"Torring PM, Larsen MJ, Brasch-Andersen C, Krogh LN, Kibaek M, Laulund L, et al. Is MED13L-related intellectual disability a recognizable syndrome? Eur J Med Genet. 2019;62:129\u201336. https:\/\/doi.org\/10.1016\/j.ejmg.2018.06.014.","journal-title":"Eur J Med Genet"},{"key":"847_CR12","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1007\/s10048-018-0541-0","volume":"19","author":"T Smol","year":"2018","unstructured":"Smol T, Petit F, Piton A, Keren B, Sanlaville D, Afenjar A, et al. MED13L-related intellectual disability: involvement of missense variants and delineation of the phenotype. Neurogenetics. 2018;19:93\u2013103. https:\/\/doi.org\/10.1007\/s10048-018-0541-0.","journal-title":"Neurogenetics"},{"key":"847_CR13","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1159\/000485638","volume":"9","author":"SM Hiatt","year":"2018","unstructured":"Hiatt SM, Bowling KM, Prokop JW, Engel KL, Cochran JN, Bebin EM, et al. Language and cognitive impairment associated with a novel p.Cys63Arg change in the MED13L transcriptional regulator. Hum Genet. 2018;9:83\u201391. https:\/\/doi.org\/10.1159\/000485638.","journal-title":"Hum Genet"},{"key":"847_CR14","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1016\/j.ejmg.2017.06.004","volume":"60","author":"R Asadollahi","year":"2017","unstructured":"Asadollahi R, Zweier M, Gogoll L, Schiffmann R, Sticht H, Steindl K, et al. Genotype-phenotype evaluation of MED13L defects in the light of a novel truncating and a recurrent missense mutation. Eur J Med Genet. 2017;60:451\u201364. https:\/\/doi.org\/10.1016\/j.ejmg.2017.06.004.","journal-title":"Eur J Med Genet"},{"key":"847_CR15","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1038\/nature10423","volume":"478","author":"H Najmabadi","year":"2011","unstructured":"Najmabadi H, Hu H, Garshasbi M, Zemojtel T, Abedini SS, Chen W, et al. Deep sequencing reveals 50 novel genes for recessive cognitive disorders. Nature. 2011;478:57\u201363. https:\/\/doi.org\/10.1038\/nature10423.","journal-title":"Nature"},{"key":"847_CR16","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1038\/nature13394","volume":"511","author":"C Gilissen","year":"2014","unstructured":"Gilissen C, Hehir-Kwa JY, Thung DT, van de Vorst M, van Bon BW, Willemsen MH, et al. Genome sequencing identifies major causes of severe intellectual disability. Nature. 2014;511:344\u20137. https:\/\/doi.org\/10.1038\/nature13394.","journal-title":"Nature"},{"key":"847_CR17","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1186\/s13229-015-0017-0","volume":"6","author":"M Codina-Sola","year":"2015","unstructured":"Codina-Sola M, Rodriguez-Santiago B, Homs A, Santoyo J, Rigau M, Aznar-Lain G, et al. Integrated analysis of whole-exome sequencing and transcriptome profiling in males with autism spectrum disorders. Mol Autism. 2015;6:21. https:\/\/doi.org\/10.1186\/s13229-015-0017-0.","journal-title":"Mol Autism"},{"key":"847_CR18","doi-asserted-by":"publisher","first-page":"809","DOI":"10.1038\/pr.2016.162","volume":"80","author":"A Caro-Llopis","year":"2016","unstructured":"Caro-Llopis A, Rosello M, Orellana C, Oltra S, Monfort S, Mayo S, et al. De novo mutations in genes of mediator complex causing syndromic intellectual disability: mediatorpathy or transcriptomopathy? Pediatr Res. 2016;80:809\u201315. https:\/\/doi.org\/10.1038\/pr.2016.162.","journal-title":"Pediatr Res"},{"key":"847_CR19","doi-asserted-by":"publisher","first-page":"833","DOI":"10.1002\/ccr3.904","volume":"5","author":"SV Mullegama","year":"2017","unstructured":"Mullegama SV, Jensik P, Li C, Dorrani N, Kantarci S, Blumberg B, et al. Coupling clinical exome sequencing with functional characterization studies to diagnose a patient with familial Mediterranean fever and MED13L haploinsufficiency syndromes. Clin Case Rep. 2017;5:833\u201340. https:\/\/doi.org\/10.1002\/ccr3.904.","journal-title":"Clin Case Rep"},{"key":"847_CR20","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1038\/gim.2015.30","volume":"17","author":"S Richards","year":"2015","unstructured":"Richards S, Aziz N, Bale S, Bick D, Das S, Gastier-Foster J, et al. Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genet Med. 2015;17:405\u201324. https:\/\/doi.org\/10.1038\/gim.2015.30.","journal-title":"Genet Med"}],"container-title":["Italian Journal of Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13052-020-00847-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13052-020-00847-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13052-020-00847-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,8]],"date-time":"2021-07-08T23:44:18Z","timestamp":1625787858000},"score":1,"resource":{"primary":{"URL":"https:\/\/ijponline.biomedcentral.com\/articles\/10.1186\/s13052-020-00847-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,7,9]]},"references-count":20,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["847"],"URL":"https:\/\/doi.org\/10.1186\/s13052-020-00847-y","relation":{},"ISSN":["1824-7288"],"issn-type":[{"value":"1824-7288","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,7,9]]},"assertion":[{"value":"18 March 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 June 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 July 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Study approval and ethical clearance was obtained from the affiliated hospital of Qingdao university. Written consent was obtained from the guardian of the child prior to data collection.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"We obtained the written consent for publication from the guardian of the patient.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"All authors declare that they do not have any conflict of interest.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"95"}}